Butterfly Network, Inc. (BFLY) has a MoatMap StockRank of 67/100 based on Quality (41/100), Value (33/100), and Momentum (77/100) factor scores. The current signal is BUY. Butterfly Network offers innovative handheld ultrasound technology, but it remains highly unprofitable with a broken business model that has failed to scale efficiently. This violates our Terry Smith and Warren Buffett rules against buying speculative turnarounds.
Butterfly Network, Inc. is a digital health company that developed the Butterfly iQ, the world's first handheld, single-probe whole-body ultrasound system. The company's competitive moat is its proprietary Ultrasound-on-a-Chip technology, which democratizes medical imaging by reducing costs and increasing portability. It operates as a disruptive medical device player targeting the global point-of-care imaging market.
| Price | $5.12 |
| Market Cap | $1.2B |
| P/E (Forward) | -56.11 |
| Price/Book | 7.09 |
| Return on Equity | -35.2% |
| Return on Invested Capital | -32.6% |
| Debt/Equity | 10.33 |
| Gross Margin | 66.1% |
| Operating Margin | -50.8% |
| Revenue Growth | 25.0% |
| Free Cash Flow | $9M |
Butterfly Network, Inc. operates in the Medical Devices industry, part of the Healthcare sector (United States).